A. Monjour

605 total citations
10 papers, 449 citations indexed

About

A. Monjour is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Neurology. According to data from OpenAlex, A. Monjour has authored 10 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Neurology. Recurrent topics in A. Monjour's work include Glioma Diagnosis and Treatment (10 papers), Brain Metastases and Treatment (4 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). A. Monjour is often cited by papers focused on Glioma Diagnosis and Treatment (10 papers), Brain Metastases and Treatment (4 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). A. Monjour collaborates with scholars based in France, United States and Netherlands. A. Monjour's co-authors include Jean‐Yves Delattre, Ronnie J. Freilich, Lisa M. DeAngelis, Alain Améri, Stéphanie Cartalat‐Carel, François Ducray, J.‐Y. Delattre, Luc Taillandier, M Poisson and Karima Mokhtari and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and European Journal of Cancer.

In The Last Decade

A. Monjour

10 papers receiving 439 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Monjour France 7 373 210 181 155 67 10 449
Denise Damek United States 9 328 0.9× 176 0.8× 143 0.8× 105 0.7× 67 1.0× 19 411
Lee McNeely United States 9 119 0.3× 196 0.9× 130 0.7× 114 0.7× 107 1.6× 12 380
Charles B. Wilson United States 9 192 0.5× 397 1.9× 127 0.7× 57 0.4× 119 1.8× 10 648
Marc C. Chamberlain United States 9 267 0.7× 82 0.4× 277 1.5× 40 0.3× 61 0.9× 9 465
Joe Mendez United States 7 385 1.0× 213 1.0× 265 1.5× 165 1.1× 117 1.7× 21 574
Samer E. Kaba United States 8 84 0.2× 155 0.7× 61 0.3× 114 0.7× 116 1.7× 11 414
Kjell Watne Norway 10 150 0.4× 56 0.3× 106 0.6× 62 0.4× 24 0.4× 16 309
Kimberly R. Porter United States 6 176 0.5× 123 0.6× 97 0.5× 30 0.2× 94 1.4× 8 345
E. Vasario Italy 9 208 0.6× 77 0.4× 131 0.7× 25 0.2× 88 1.3× 13 343
Özlem Yapıcıer Türkiye 10 133 0.4× 136 0.6× 88 0.5× 50 0.3× 119 1.8× 63 416

Countries citing papers authored by A. Monjour

Since Specialization
Citations

This map shows the geographic impact of A. Monjour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Monjour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Monjour more than expected).

Fields of papers citing papers by A. Monjour

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Monjour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Monjour. The network helps show where A. Monjour may publish in the future.

Co-authorship network of co-authors of A. Monjour

This figure shows the co-authorship network connecting the top 25 collaborators of A. Monjour. A scholar is included among the top collaborators of A. Monjour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Monjour. A. Monjour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Bompaire, Flavie, M. Lahutte, Karima Mokhtari, et al.. (2016). SMART syndrome: Classic transient symptoms leading to an unusual unfavorable outcome. Revue Neurologique. 173(1-2). 67–73. 7 indexed citations
2.
Monjour, A., et al.. (2012). SMART Syndrome : à propos d’un cas d’une complication rare après radiothérapie cérébrale et revue de la littérature. Cancer/Radiothérapie. 16(4). 295–301. 2 indexed citations
3.
Pérez‐Larraya, Jaime Gállego, François Ducray, Olivier Chinot, et al.. (2011). Temozolomide in Elderly Patients With Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial. Journal of Clinical Oncology. 29(22). 3050–3055. 160 indexed citations
4.
Rheims, Sylvain, Damien Ricard, Martin J. van den Bent, et al.. (2011). Peri-ictal pseudoprogression in patients with brain tumor. Neuro-Oncology. 13(7). 775–782. 24 indexed citations
5.
Napolitano, Massimo, Florence Keime-Guibert, A. Monjour, et al.. (1999). Treatment of Supratentorial Glioblastoma Multiforme with Radiotherapy and a Combination of BCNU and Tamoxifen: A Phase II Study. Journal of Neuro-Oncology. 45(3). 229–235. 13 indexed citations
6.
Freilich, Ronnie J., Jean‐Yves Delattre, A. Monjour, & Lisa M. DeAngelis. (1996). Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients. Neurology. 46(2). 435–439. 171 indexed citations
7.
Sanson, Marc, Alain Améri, A. Monjour, et al.. (1996). Treatment of recurrent malignant supratentorial gliomas with ifosfamide, carboplatin and etoposide: a phase II study. European Journal of Cancer. 32(13). 2229–2235. 37 indexed citations
9.
Sarazin, Marie, et al.. (1995). Primary central nervous system lymphoma: Treatment with chemotherapy and radiotherapy. European Journal of Cancer. 31(12). 2003–2007. 28 indexed citations
10.
Monjour, A., et al.. (1992). [Primary non-Hodgkin's malignant lymphoma of the central nervous system].. PubMed. 148(10). 589–600. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026